Mount Sinai Hospital
600 University Avenue
Dr. Greenblatt is Medical Director, Mount Sinai Fertility, and Head,
Division of Reproductive Endocrinology and Infertility, Obstetrics and
Gynecology, Mount Sinai Hospital. She is also an Associate Professor,
Reproductive Endocrinology and Infertility, Obstetrics and Gynaecology,
Department of Medicine, University of Toronto.
Dr. Greenblatt received her medical degree from McGill University and
undertook additional training at McGill University, Western University
and University of California, San Francisco where she was funded by an
Her work has made important contributions to current practices in
fertility preservation in young adults with cancer, as well as
improving outcomes and limiting complications as a result of assisted
reproductive treatments (ARTs) In 2010 she was recognized by the Royal
Society of Physicians and Surgeons of Canada as being instrumental in
the development of Gynecologic Endocrinology and Infertility as a
medical speciality. In 2014, she received recognition from the
organization Fertile Future for her ongoing commitment to enhancing
fertility outcomes for people facing cancer.
Her research interests focus on:
-Fertility preservation in adolescents and young adults with
-Endometrial receptivity, specifically in the development of
non-invasive biomarkers to improve the prediction of embryo
implantation and allow single embryo transfer.
-Improving outcomes from assisted reproductive technologies (ARTs),
specifically decreasing multiple pregnancies and ovarian
-Barriers to reproduction in overweight and obese women.
Her research has been funded by Medical Research Council of Canada
(MRCC), Canadian Institutes of Health Research (CIHR), Canadian Celiac
Association (CCA), Physicians’ Services Incorporated Foundation (PSI),
Canadian Cancer Society (CCS), Quebec Ministry of Health, Canadian
Breast Cancer Foundation (CBCF), Susan Komen Breast Cancer Foundation
as well as an Innovation Grant from the Academic Health Science Centre
(AHSC) Academic Funding Plan (AFP). Dr Greenblatt was the first
Canadian awarded a Grant for Fertility Innovation (EMD Serono).
Dr. Greenblatt has consulted nationally and internationally in her
field and with patient advocacy groups. She is a past national director
of the Canadian Fertility and Andrology Society, Current Canadian
member of the Oncofertility Consortium Global Network and she has
published more than 40 articles in peer-reviewed journals.